Breaking News Instant updates and real-time market news.

BYSI

BeyondSpring

$27.55

0.33 (1.21%)

07:19
05/17/18
05/17
07:19
05/17/18
07:19

BeyondSpring to present prospective Phase 2/3 trial of Plinabulin at ASCO

BeyondSpring announced that the company will present results of the Phase 2 portion of Study 105, a prospective Phase 2/3 trial of its lead asset, Plinabulin, during a poster presentation at the American Society of Clinical Oncology, or ASCO, Annual Meeting on June 4, 2018. Importantly, data from the study demonstrated that patients treated with Plinabulin dosed 30 minutes after docetaxel for the prevention of docetaxel chemotherapy-induced neutropenia, or CIN, reported less bone pain, which was clinically meaningful, and had superior neutrophil counts and comparable neutropenia reduction compared to patients treated with Neulasta 24 hours after docetaxel. These findings suggest that Plinabulin has the potential for an overall superior product profile in the prevention of CIN.

BYSI BeyondSpring
$27.55

0.33 (1.21%)

10/26/17
HCWC
10/26/17
NO CHANGE
Target $60
HCWC
Buy
BeyondSpring price target raised to $60 from $50 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for BeyondSpring to $60 saying new regulatory rules in China may accelerate Plinabulin approval. The CPC Central Committee and State Council of China's new regulatory guidelines should be beneficial to BeyondSpring by accelerating approval and extending intellectual property protection, Pantginis tells investors in a research note. He keeps a Buy rating o the shares.
12/05/17
GHSC
12/05/17
INITIATION
Target $56
GHSC
Buy
BeyondSpring initiated with a Buy at Seaport Global
Seaport Global analyst Vernon Bernardino initiated BeyondSpring with a Buy and $56 price target saying its lead drug, Plinabulin, is a differentiated standard in the potential treatment option for chemotherapy-induced neutropenia (CIN). He thinks Plinabulin could also play a key role in improving results with traditional cancer drugs and immunotherapies that are limited by their significant toxicities.
03/01/18
HCWC
03/01/18
NO CHANGE
Target $60
HCWC
Buy
BeyondSpring recent selloff unwarranted, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis views the 17.5% selloff in shares of BeyondSpring since the February 21 announced departure of CFO Richard Brand as unwarranted. After speaking to management, the analyst believes a new CFO will be a positive as the company moves closer to pivotal data and potential commercialization of Plinabulin. He keeps a Buy rating on BeyondSpring with a $60 price target.
03/19/18
HCWC
03/19/18
NO CHANGE
HCWC
BeyondSpring 'hits ground running' with Phase 3 study, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis noted that BeyondSpring just announced the initiation of its Phase 3 Study 105 non-inferiority head-to-head study of Plinabulin compared to Neulasta for prevention of docetaxel chemotherapy induced neutropenia. Pantginis sees a possible Plinabulin NDA filing with the China Food and Drug Administration within one year, and maintained a Buy rating and $60 price target on BeyondSpring shares.

TODAY'S FREE FLY STORIES

ABX

Barrick Gold

$13.82

-0.07 (-0.50%)

10:30
12/19/18
12/19
10:30
12/19/18
10:30
Options
Heavy volume in Barrick Gold downside Jan puts »

Heavy volume in Barrick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$10.99

-0.05 (-0.45%)

10:29
12/19/18
12/19
10:29
12/19/18
10:29
Initiation
JinkoSolar initiated  »

JinkoSolar initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Dec

10:25
12/19/18
12/19
10:25
12/19/18
10:25
General news
Treasury Action: flattening is the trade ahead of the FOMC »

Treasury Action:…

10:25
12/19/18
12/19
10:25
12/19/18
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

10:25
12/19/18
12/19
10:25
12/19/18
10:25
Conference/Events
UBS retail analyst to hold an analyst/industry conference call »

Retail Analyst Sole…

10:20
12/19/18
12/19
10:20
12/19/18
10:20
General news
FX Action: The dollar »

FX Action: The dollar…

SPY

SPDR S&P 500 ETF Trust

$257.02

1.93 (0.76%)

10:20
12/19/18
12/19
10:20
12/19/18
10:20
Options
Size ratio spread in SPYders weekly options »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
12/19/18
12/19
10:20
12/19/18
10:20
General news
Treasury Action: yields remained pinned lower »

Treasury Action: yields…

ULTA

Ulta Beauty

$245.00

4.07 (1.69%)

, MTCH

Match Group

$42.58

0.6 (1.43%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ULTA

Ulta Beauty

$245.00

4.07 (1.69%)

MTCH

Match Group

$42.58

0.6 (1.43%)

SSTI

ShotSpotter

$30.30

1.12 (3.84%)

OKTA

Okta

$66.09

3.32 (5.29%)

CLLS

Cellectis

$18.35

0.6 (3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 09

    Jan

  • 16

    Jan

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

, ADI

Analog Devices

$87.50

-0.57 (-0.65%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

ADI

Analog Devices

$87.50

-0.57 (-0.65%)

UAA

Under Armour

$18.63

-0.18 (-0.96%)

UA

Under Armour

$17.21

-0.18 (-1.04%)

MU

Micron

$33.30

-0.82 (-2.40%)

JPM

JPMorgan

$99.31

0.79 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 08

    Jan

  • 08

    Jan

  • 31

    Jan

  • 26

    Feb

  • 03

    Mar

MDT

Medtronic

$92.20

0.18 (0.20%)

, MASI

Masimo

$106.37

1.08 (1.03%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

MDT

Medtronic

$92.20

0.18 (0.20%)

MASI

Masimo

$106.37

1.08 (1.03%)

DRI

Darden

$103.74

-0.08 (-0.08%)

BBY

Best Buy

$52.56

0.57 (1.10%)

GE

General Electric

$7.78

0.505 (6.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/19/18
12/19
10:17
12/19/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/19/18
12/19
10:16
12/19/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/19/18
12/19
10:15
12/19/18
10:15
General news
U.S. existing home sales rose 1.9% to 5.320 M in November »

U.S. existing home sales…

10:15
12/19/18
12/19
10:15
12/19/18
10:15
General news
Breaking General news story  »

Week of 12/14 EIA…

XLU

Utilities SPDR

$54.42

-0.21 (-0.38%)

10:10
12/19/18
12/19
10:10
12/19/18
10:10
Options
18.8K SPDR Utility Fund Dec 51 - 53 put spreads trade 12c »

18.8K SPDR Utility Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FND

Floor & Decor

$26.63

0.09 (0.34%)

10:06
12/19/18
12/19
10:06
12/19/18
10:06
Recommendations
Floor & Decor analyst commentary  »

Morgan Stanley says Floor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$35.14

0.73 (2.12%)

10:05
12/19/18
12/19
10:05
12/19/18
10:05
Hot Stocks
BorgWarner extends agreement to be Official Turbocharger Partner of INDYCAR »

BorgWarner and INDYCAR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEED

Origin Agritech

$6.37

(0.00%)

10:03
12/19/18
12/19
10:03
12/19/18
10:03
Hot Stocks
Origin Agritech announces establishment of two additional joint ventures »

Origin Agritech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
12/19/18
12/19
10:02
12/19/18
10:02
General news
Existing Home Sales data reported »

November Existing Home…

APD

Air Products

$156.68

1.95 (1.26%)

10:02
12/19/18
12/19
10:02
12/19/18
10:02
Hot Stocks
Air Products to supply three nitrogen generation plants to energy project »

Air Products and N.V.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$169.62

-15.39 (-8.32%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
FedEx falls -8.4% »

FedEx is down -8.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSI

FTS International

$7.54

-0.7 (-8.50%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
FTS International falls -8.6% »

FTS International is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

UGAZ

VelocityShares 3x Long Natural Gas ETN

$73.20

-14.04 (-16.09%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -15.9% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil

$24.37

2.16 (9.73%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
Jabil rises 9.8% »

Jabil is up 9.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.